Hassam Ali, Faisal Inayat, Vishali Moond, Ahtshamullah Chaudhry, Arslan Afzal, Zauraiz Anjum, Hamza Tahir, Muhammad Sajeel Anwar, Dushyant Singh Dahiya, Muhammad Sohaib Afzal, Gul Nawaz, Amir H Sohail, Muhammad Aziz
BACKGROUND: Roux-en-Y gastric bypass (RYGB) is a widely recognized bariatric procedure that is particularly beneficial for patients with class III obesity. It aids in significant weight loss and improves obesity-related medical conditions. Despite its effectiveness, postoperative care still has challenges. Clinical evidence shows that venous thromboembolism (VTE) is a leading cause of 30-d morbidity and mortality after RYGB. Therefore, a clear unmet need exists for a tailored risk assessment tool for VTE in RYGB candidates...
April 27, 2024: World Journal of Gastrointestinal Surgery